Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BARDA
Biotech
Regeneron snags $326M from BARDA for next-gen COVID antibody
BARDA has tapped Regeneron for a next-generation COVID-19 antibody therapy, promising up to $326 million in the hope of starting trials this year.
James Waldron
Aug 23, 2023 7:15am
BARDA backs Satio's development of a patch-based Ebola test
Aug 21, 2023 10:57am
Eagle swoops down to nab chunk of BARDA-backed Enalare
Aug 9, 2022 11:22am
Veru wraps up COVID trial early and heads to regulators
Apr 11, 2022 10:30am
Biden aims to halve cancer death rate, forms cancer cabinet
Feb 2, 2022 10:12am
Coalition urges NIH to disclose cost of federally-funded trials
Feb 1, 2022 10:08am
